1	(	_	-LRB-	-LRB-	_	30	P	_	_
2	@	_	RB	RB	_	7	NMOD	_	_
3	entity0	_	CD	CD	_	2	AMOD	_	_
4	)	_	-RRB-	-RRB-	_	3	P	_	_
5	--	_	:	:	_	7	P	_	_
6	new	_	JJ	JJ	_	7	NMOD	_	_
7	tests	_	NNS	NNS	_	8	SUB	_	_
8	suggest	_	VBP	VBP	_	30	VMOD	_	_
9	how	_	WRB	WRB	_	8	VMOD	_	_
10	a	_	DT	DT	_	11	NMOD	_	_
11	contaminant	_	NN	NN	_	19	SUB	_	_
12	in	_	IN	IN	_	11	NMOD	_	_
13	heparin	_	NN	NN	_	12	PMOD	_	_
14	--	_	:	:	_	16	P	_	_
15	a	_	DT	DT	_	16	NMOD	_	_
16	blood	_	NN	NN	_	11	NMOD	_	_
17	thinner	_	JJR	JJR	_	16	NMOD	_	_
18	--	_	:	:	_	16	P	_	_
19	may	_	MD	MD	_	9	SBAR	_	_
20	be	_	VB	VB	_	19	VC	_	_
21	connected	_	VBN	VBN	_	20	VC	_	_
22	to	_	TO	TO	_	21	VMOD	_	_
23	dozens	_	NNS	NNS	_	22	PMOD	_	_
24	of	_	IN	IN	_	23	NMOD	_	_
25	deaths	_	NNS	NNS	_	24	PMOD	_	_
26	,	_	,	,	_	30	P	_	_
27	@	_	RB	RB	_	29	NMOD	_	_
28	entity2	_	CD	CD	_	29	NMOD	_	_
29	officials	_	NNS	NNS	_	30	SUB	_	_
30	said	_	VBD	VBD	_	0	ROOT	_	_
31	monday	_	NNP	NNP	_	30	VMOD	_	_

1	@	_	NNP	NNP	_	8	NMOD	_	_
2	entity8	_	CD	CD	_	1	NMOD	_	_
3	,	_	,	,	_	8	P	_	_
4	a	_	DT	DT	_	8	NMOD	_	_
5	@	_	JJ	JJ	_	8	NMOD	_	_
6	entity9	_	CD	CD	_	8	NMOD	_	_
7	health	_	NN	NN	_	8	NMOD	_	_
8	official	_	NN	NN	_	10	SUB	_	_
9	,	_	,	,	_	8	P	_	_
10	says	_	VBZ	VBZ	_	0	ROOT	_	_
11	he	_	PRP	PRP	_	12	SUB	_	_
12	doubts	_	VBZ	VBZ	_	10	VMOD	_	_
13	@	_	JJ	JJ	_	14	NMOD	_	_
14	entity9	_	CD	CD	_	15	SUB	_	_
15	is	_	VBZ	VBZ	_	12	VMOD	_	_
16	to	_	TO	TO	_	17	VMOD	_	_
17	blame	_	VB	VB	_	15	PRD	_	_
18	for	_	IN	IN	_	17	VMOD	_	_
19	the	_	DT	DT	_	21	NMOD	_	_
20	heparin	_	NN	NN	_	21	NMOD	_	_
21	problem	_	NN	NN	_	18	PMOD	_	_

1	the	_	DT	DT	_	3	NMOD	_	_
2	@	_	JJ	JJ	_	3	NMOD	_	_
3	entity2	_	NN	NN	_	4	SUB	_	_
4	has	_	VBZ	VBZ	_	23	VMOD	_	_
5	``	_	``	``	_	4	P	_	_
6	now	_	RB	RB	_	4	VMOD	_	_
7	established	_	VBN	VBN	_	4	VC	_	_
8	a	_	DT	DT	_	9	NMOD	_	_
9	mechanism	_	NN	NN	_	7	OBJ	_	_
10	by	_	IN	IN	_	9	NMOD	_	_
11	which	_	WDT	WDT	_	10	PMOD	_	_
12	we	_	PRP	PRP	_	13	SUB	_	_
13	think	_	VBP	VBP	_	10	SBAR	_	_
14	this	_	DT	DT	_	15	NMOD	_	_
15	contaminant	_	NN	NN	_	16	SUB	_	_
16	could	_	MD	MD	_	13	VMOD	_	_
17	cause	_	VB	VB	_	16	VC	_	_
18	these	_	DT	DT	_	20	NMOD	_	_
19	adverse	_	JJ	JJ	_	20	NMOD	_	_
20	events	_	NNS	NNS	_	17	OBJ	_	_
21	,	_	,	,	_	23	P	_	_
22	``	_	``	``	_	23	P	_	_
23	said	_	VBD	VBD	_	0	ROOT	_	_
24	dr	_	NN	NN	_	23	VMOD	_	_

1	@	_	NNP	NNP	_	0	ROOT	_	_
2	entity11	_	CD	CD	_	1	NMOD	_	_
3	,	_	,	,	_	1	P	_	_
4	director	_	NN	NN	_	1	NMOD	_	_
5	of	_	IN	IN	_	4	NMOD	_	_
6	the	_	DT	DT	_	9	NMOD	_	_
7	@	_	JJ	JJ	_	9	NMOD	_	_
8	entity2	_	NN	NN	_	9	NMOD	_	_
9	's	_	POS	POS	_	11	NMOD	_	_
10	@	_	NN	NN	_	11	NMOD	_	_
11	entity12	_	NN	NN	_	5	PMOD	_	_

1	she	_	PRP	PRP	_	2	SUB	_	_
2	said	_	VBD	VBD	_	0	ROOT	_	_
3	contaminated	_	VBN	VBN	_	4	NMOD	_	_
4	shipments	_	NNS	NNS	_	9	SUB	_	_
5	of	_	IN	IN	_	4	NMOD	_	_
6	the	_	DT	DT	_	7	NMOD	_	_
7	blood	_	NN	NN	_	5	PMOD	_	_
8	thinner	_	JJR	JJR	_	7	NMOD	_	_
9	have	_	VBP	VBP	_	2	VMOD	_	_
10	been	_	VBN	VBN	_	9	VC	_	_
11	traced	_	VBN	VBN	_	10	VC	_	_
12	from	_	IN	IN	_	11	VMOD	_	_
13	@	_	VBG	VBG	_	12	PMOD	_	_
14	entity9	_	CD	CD	_	16	AMOD	_	_
15	to	_	TO	TO	_	16	AMOD	_	_
16	10	_	CD	CD	_	17	NMOD	_	_
17	countries	_	NNS	NNS	_	13	OBJ	_	_
18	,	_	,	,	_	17	P	_	_
19	including	_	VBG	VBG	_	17	NMOD	_	_
20	the	_	DT	DT	_	22	NMOD	_	_
21	@	_	JJ	JJ	_	22	NMOD	_	_
22	entity20	_	CD	CD	_	19	PMOD	_	_

1	``	_	``	``	_	14	P	_	_
2	contamination	_	NN	NN	_	7	SUB	_	_
3	of	_	IN	IN	_	2	NMOD	_	_
4	the	_	DT	DT	_	6	NMOD	_	_
5	heparin	_	JJ	JJ	_	6	NMOD	_	_
6	supply	_	NN	NN	_	3	PMOD	_	_
7	is	_	VBZ	VBZ	_	14	VMOD	_	_
8	a	_	DT	DT	_	10	NMOD	_	_
9	worldwide	_	NNP	NNP	_	10	NMOD	_	_
10	problem	_	NN	NN	_	7	PRD	_	_
11	,	_	,	,	_	14	P	_	_
12	``	_	``	``	_	14	P	_	_
13	she	_	PRP	PRP	_	14	SUB	_	_
14	said	_	VBD	VBD	_	0	ROOT	_	_

1	heparin	_	NNP	NNP	_	2	SUB	_	_
2	containing	_	VBG	VBG	_	5	NMOD	_	_
3	oversulfated	_	JJ	JJ	_	5	NMOD	_	_
4	chondroitin	_	JJ	JJ	_	5	NMOD	_	_
5	sulfate	_	NN	NN	_	39	NMOD	_	_
6	--	_	:	:	_	39	P	_	_
7	a	_	DT	DT	_	8	NMOD	_	_
8	compound	_	NN	NN	_	14	SUB	_	_
9	made	_	VBN	VBN	_	8	NMOD	_	_
10	from	_	IN	IN	_	9	VMOD	_	_
11	animal	_	JJ	JJ	_	12	NMOD	_	_
12	cartilage	_	NN	NN	_	10	PMOD	_	_
13	--	_	:	:	_	8	P	_	_
14	has	_	VBZ	VBZ	_	39	VMOD	_	_
15	been	_	VBN	VBN	_	14	VC	_	_
16	associated	_	VBN	VBN	_	15	VC	_	_
17	with	_	IN	IN	_	16	VMOD	_	_
18	hundreds	_	NNS	NNS	_	17	PMOD	_	_
19	of	_	IN	IN	_	18	NMOD	_	_
20	serious	_	JJ	JJ	_	22	NMOD	_	_
21	adverse	_	JJ	JJ	_	22	NMOD	_	_
22	symptoms	_	NNS	NNS	_	19	PMOD	_	_
23	,	_	,	,	_	22	P	_	_
24	including	_	VBG	VBG	_	22	NMOD	_	_
25	allergic	_	JJ	JJ	_	26	NMOD	_	_
26	reactions	_	NNS	NNS	_	24	PMOD	_	_
27	that	_	WDT	WDT	_	26	NMOD	_	_
28	cause	_	VBP	VBP	_	27	SBAR	_	_
29	nausea	_	NN	NN	_	28	OBJ	_	_
30	,	_	,	,	_	39	P	_	_
31	vomiting	_	NN	NN	_	39	NMOD	_	_
32	,	_	,	,	_	39	P	_	_
33	shortness	_	NN	NN	_	39	NMOD	_	_
34	of	_	IN	IN	_	33	NMOD	_	_
35	breath	_	NN	NN	_	34	PMOD	_	_
36	and	_	CC	CC	_	39	NMOD	_	_
37	a	_	DT	DT	_	39	NMOD	_	_
38	severe	_	JJ	JJ	_	39	NMOD	_	_
39	drop	_	NN	NN	_	0	ROOT	_	_
40	in	_	IN	IN	_	39	NMOD	_	_
41	blood	_	NN	NN	_	42	NMOD	_	_
42	pressure	_	NN	NN	_	40	PMOD	_	_

1	in	_	IN	IN	_	7	VMOD	_	_
2	addition	_	NN	NN	_	1	PMOD	_	_
3	,	_	,	,	_	7	P	_	_
4	the	_	DT	DT	_	6	NMOD	_	_
5	@	_	NN	NN	_	6	NMOD	_	_
6	entity2	_	NN	NN	_	7	SUB	_	_
7	has	_	VBZ	VBZ	_	24	VMOD	_	_
8	tallied	_	VBN	VBN	_	7	VC	_	_
9	81	_	CD	CD	_	10	NMOD	_	_
10	deaths	_	NNS	NNS	_	8	OBJ	_	_
11	related	_	VBN	VBN	_	10	NMOD	_	_
12	to	_	TO	TO	_	11	VMOD	_	_
13	those	_	DT	DT	_	14	NMOD	_	_
14	symptoms	_	NNS	NNS	_	12	PMOD	_	_
15	in	_	IN	IN	_	14	NMOD	_	_
16	the	_	DT	DT	_	17	NMOD	_	_
17	@	_	NN	NN	_	15	PMOD	_	_
18	entity20	_	CD	CD	_	17	NMOD	_	_
19	,	_	,	,	_	24	P	_	_
20	though	_	IN	IN	_	24	VMOD	_	_
21	no	_	DT	DT	_	23	NMOD	_	_
22	causal	_	JJ	JJ	_	23	NMOD	_	_
23	link	_	NN	NN	_	24	SUB	_	_
24	has	_	VBZ	VBZ	_	0	ROOT	_	_
25	been	_	VBN	VBN	_	24	VC	_	_
26	determined	_	VBN	VBN	_	25	VC	_	_

1	the	_	DT	DT	_	3	NMOD	_	_
2	severe	_	JJ	JJ	_	3	NMOD	_	_
3	reactions	_	NNS	NNS	_	4	SUB	_	_
4	seem	_	VBP	VBP	_	21	VMOD	_	_
5	to	_	TO	TO	_	6	VMOD	_	_
6	be	_	VB	VB	_	4	VMOD	_	_
7	related	_	VBN	VBN	_	6	VC	_	_
8	to	_	TO	TO	_	7	VMOD	_	_
9	patients	_	NNS	NNS	_	8	PMOD	_	_
10	who	_	WP	WP	_	9	NMOD	_	_
11	were	_	VBD	VBD	_	10	SBAR	_	_
12	given	_	VBN	VBN	_	11	VC	_	_
13	high	_	JJ	JJ	_	14	NMOD	_	_
14	doses	_	NNS	NNS	_	12	OBJ	_	_
15	of	_	IN	IN	_	14	NMOD	_	_
16	the	_	DT	DT	_	17	NMOD	_	_
17	drug	_	NN	NN	_	15	PMOD	_	_
18	,	_	,	,	_	21	P	_	_
19	@	_	VBP	VBP	_	21	VMOD	_	_
20	entity11	_	CD	CD	_	19	VMOD	_	_
21	said	_	VBD	VBD	_	0	ROOT	_	_

1	she	_	PRP	PRP	_	2	SUB	_	_
2	said	_	VBD	VBD	_	26	VMOD	_	_
3	she	_	PRP	PRP	_	4	SUB	_	_
4	would	_	MD	MD	_	2	VMOD	_	_
5	not	_	RB	RB	_	4	VMOD	_	_
6	detail	_	NN	NN	_	4	VC	_	_
7	the	_	DT	DT	_	9	NMOD	_	_
8	suspected	_	VBN	VBN	_	9	NMOD	_	_
9	problems	_	NNS	NNS	_	6	OBJ	_	_
10	with	_	IN	IN	_	9	NMOD	_	_
11	the	_	DT	DT	_	12	NMOD	_	_
12	contaminant	_	NN	NN	_	10	PMOD	_	_
13	in	_	IN	IN	_	12	NMOD	_	_
14	heparin	_	NN	NN	_	13	PMOD	_	_
15	until	_	IN	IN	_	12	NMOD	_	_
16	the	_	DT	DT	_	17	NMOD	_	_
17	information	_	NN	NN	_	18	SUB	_	_
18	is	_	VBZ	VBZ	_	15	SBAR	_	_
19	published	_	VBN	VBN	_	18	VC	_	_
20	in	_	IN	IN	_	19	VMOD	_	_
21	scientific	_	JJ	JJ	_	22	NMOD	_	_
22	literature	_	NN	NN	_	20	PMOD	_	_
23	and	_	CC	CC	_	26	VMOD	_	_
24	other	_	JJ	JJ	_	25	NMOD	_	_
25	researchers	_	NNS	NNS	_	26	SUB	_	_
26	have	_	VBP	VBP	_	0	ROOT	_	_
27	had	_	VBN	VBN	_	26	VC	_	_
28	a	_	DT	DT	_	29	NMOD	_	_
29	chance	_	NN	NN	_	27	OBJ	_	_
30	to	_	TO	TO	_	31	VMOD	_	_
31	weigh	_	VB	VB	_	29	NMOD	_	_
32	in	_	IN	IN	_	31	VMOD	_	_
33	on	_	IN	IN	_	31	VMOD	_	_
34	the	_	DT	DT	_	35	NMOD	_	_
35	matter	_	NN	NN	_	33	PMOD	_	_

1	contaminated	_	VBN	VBN	_	2	NMOD	_	_
2	heparin	_	NN	NN	_	3	SUB	_	_
3	has	_	VBZ	VBZ	_	35	VMOD	_	_
4	been	_	VBN	VBN	_	3	VC	_	_
5	discovered	_	VBN	VBN	_	4	VC	_	_
6	in	_	IN	IN	_	5	VMOD	_	_
7	@	_	NN	NN	_	6	PMOD	_	_
8	entity9	_	CD	CD	_	7	NMOD	_	_
9	,	_	,	,	_	5	P	_	_
10	@	_	RB	RB	_	5	VMOD	_	_
11	entity52	_	CD	CD	_	10	AMOD	_	_
12	,	_	,	,	_	5	P	_	_
13	@	_	RB	RB	_	5	VMOD	_	_
14	entity53	_	CD	CD	_	13	AMOD	_	_
15	,	_	,	,	_	5	P	_	_
16	@	_	RB	RB	_	5	VMOD	_	_
17	entity54	_	CD	CD	_	16	AMOD	_	_
18	,	_	,	,	_	5	P	_	_
19	@	_	RB	RB	_	5	VMOD	_	_
20	entity55	_	CD	CD	_	19	AMOD	_	_
21	,	_	,	,	_	5	P	_	_
22	@	_	RB	RB	_	5	VMOD	_	_
23	entity56	_	CD	CD	_	22	AMOD	_	_
24	,	_	,	,	_	5	P	_	_
25	@	_	RB	RB	_	5	VMOD	_	_
26	entity57	_	CD	CD	_	25	AMOD	_	_
27	,	_	,	,	_	35	P	_	_
28	the	_	DT	DT	_	29	NMOD	_	_
29	@	_	NN	NN	_	35	SUB	_	_
30	entity58	_	CD	CD	_	29	NMOD	_	_
31	,	_	,	,	_	29	P	_	_
32	@	_	RB	RB	_	29	NMOD	_	_
33	entity59	_	CD	CD	_	32	AMOD	_	_
34	,	_	,	,	_	29	P	_	_
35	@	_	VBP	VBP	_	0	ROOT	_	_
36	entity60	_	CD	CD	_	35	OBJ	_	_
37	and	_	CC	CC	_	35	VMOD	_	_
38	the	_	DT	DT	_	40	NMOD	_	_
39	@	_	NN	NN	_	40	NMOD	_	_
40	entity20	_	NN	NN	_	35	OBJ	_	_

1	@	_	NNP	NNP	_	6	NMOD	_	_
2	entity60	_	CD	CD	_	1	NMOD	_	_
3	and	_	CC	CC	_	6	NMOD	_	_
4	the	_	DT	DT	_	6	NMOD	_	_
5	@	_	JJ	JJ	_	6	NMOD	_	_
6	entity20	_	CD	CD	_	7	SUB	_	_
7	are	_	VBP	VBP	_	32	VMOD	_	_
8	the	_	DT	DT	_	10	NMOD	_	_
9	only	_	JJ	JJ	_	10	NMOD	_	_
10	countries	_	NNS	NNS	_	7	PRD	_	_
11	that	_	WDT	WDT	_	10	NMOD	_	_
12	have	_	VBP	VBP	_	11	SBAR	_	_
13	linked	_	VBN	VBN	_	12	VC	_	_
14	adverse	_	JJ	JJ	_	15	NMOD	_	_
15	events	_	NNS	NNS	_	13	OBJ	_	_
16	to	_	TO	TO	_	15	NMOD	_	_
17	the	_	DT	DT	_	18	NMOD	_	_
18	drug	_	NN	NN	_	16	PMOD	_	_
19	,	_	,	,	_	25	P	_	_
20	but	_	CC	CC	_	25	VMOD	_	_
21	cases	_	NNS	NNS	_	25	SUB	_	_
22	in	_	IN	IN	_	21	NMOD	_	_
23	other	_	JJ	JJ	_	24	NMOD	_	_
24	countries	_	NNS	NNS	_	22	PMOD	_	_
25	may	_	MD	MD	_	11	SBAR	_	_
26	have	_	VB	VB	_	25	VC	_	_
27	gone	_	VBN	VBN	_	26	VC	_	_
28	unnoticed	_	JJ	JJ	_	27	VMOD	_	_
29	,	_	,	,	_	32	P	_	_
30	@	_	JJ	JJ	_	32	SUB	_	_
31	entity11	_	CD	CD	_	30	AMOD	_	_
32	said	_	VBD	VBD	_	0	ROOT	_	_

1	still	_	RB	RB	_	5	VMOD	_	_
2	,	_	,	,	_	5	P	_	_
3	agency	_	NN	NN	_	4	NMOD	_	_
4	officials	_	NNS	NNS	_	5	SUB	_	_
5	stressed	_	VBD	VBD	_	0	ROOT	_	_
6	monday	_	NNP	NNP	_	5	VMOD	_	_
7	that	_	IN	IN	_	5	VMOD	_	_
8	they	_	PRP	PRP	_	9	SUB	_	_
9	can	_	MD	MD	_	7	SBAR	_	_
10	not	_	RB	RB	_	9	VMOD	_	_
11	be	_	VB	VB	_	9	VC	_	_
12	sure	_	JJ	JJ	_	11	PRD	_	_
13	the	_	DT	DT	_	14	NMOD	_	_
14	deaths	_	NNS	NNS	_	15	SUB	_	_
15	are	_	VBP	VBP	_	12	AMOD	_	_
16	linked	_	VBN	VBN	_	15	VC	_	_
17	to	_	TO	TO	_	16	VMOD	_	_
18	the	_	DT	DT	_	19	NMOD	_	_
19	drug	_	NN	NN	_	17	PMOD	_	_
20	,	_	,	,	_	19	P	_	_
21	which	_	WDT	WDT	_	19	NMOD	_	_
22	is	_	VBZ	VBZ	_	21	SBAR	_	_
23	made	_	VBN	VBN	_	22	VC	_	_
24	from	_	IN	IN	_	23	VMOD	_	_
25	pig	_	NN	NN	_	26	NMOD	_	_
26	intestines	_	NNS	NNS	_	24	PMOD	_	_
27	and	_	CC	CC	_	22	VMOD	_	_
28	is	_	VBZ	VBZ	_	22	VMOD	_	_
29	given	_	VBN	VBN	_	28	VC	_	_
30	to	_	TO	TO	_	31	VMOD	_	_
31	prevent	_	VB	VB	_	29	VMOD	_	_
32	clot	_	NN	NN	_	33	NMOD	_	_
33	formation	_	NN	NN	_	31	OBJ	_	_

1	``	_	``	``	_	26	P	_	_
2	we	_	PRP	PRP	_	3	SUB	_	_
3	are	_	VBP	VBP	_	26	VMOD	_	_
4	not	_	RB	RB	_	3	VMOD	_	_
5	able	_	JJ	JJ	_	3	PRD	_	_
6	to	_	TO	TO	_	7	VMOD	_	_
7	rule	_	VB	VB	_	5	AMOD	_	_
8	out	_	RP	RP	_	7	VMOD	_	_
9	the	_	DT	DT	_	10	NMOD	_	_
10	fact	_	NN	NN	_	7	OBJ	_	_
11	that	_	IN	IN	_	10	NMOD	_	_
12	there	_	EX	EX	_	13	SUB	_	_
13	could	_	MD	MD	_	11	SBAR	_	_
14	be	_	VB	VB	_	13	VC	_	_
15	other	_	JJ	JJ	_	16	NMOD	_	_
16	problems	_	NNS	NNS	_	14	PRD	_	_
17	leading	_	VBG	VBG	_	16	NMOD	_	_
18	to	_	TO	TO	_	17	VMOD	_	_
19	these	_	DT	DT	_	21	NMOD	_	_
20	adverse	_	JJ	JJ	_	21	NMOD	_	_
21	events	_	NNS	NNS	_	18	PMOD	_	_
22	,	_	,	,	_	26	P	_	_
23	``	_	``	``	_	26	P	_	_
24	@	_	NN	NN	_	25	NMOD	_	_
25	entity11	_	NN	NN	_	26	SUB	_	_
26	said	_	VBD	VBD	_	0	ROOT	_	_

1	earlier	_	JJR	JJR	_	2	NMOD	_	_
2	monday	_	NNP	NNP	_	4	SUB	_	_
3	,	_	,	,	_	4	P	_	_
4	@	_	VBD	VBD	_	0	ROOT	_	_
5	entity9	_	CD	CD	_	6	NMOD	_	_
6	officials	_	NNS	NNS	_	7	SUB	_	_
7	said	_	VBD	VBD	_	4	VMOD	_	_
8	they	_	PRP	PRP	_	9	SUB	_	_
9	were	_	VBD	VBD	_	7	VMOD	_	_
10	doubtful	_	JJ	JJ	_	9	PRD	_	_
11	a	_	DT	DT	_	12	NMOD	_	_
12	contaminant	_	NN	NN	_	15	SUB	_	_
13	in	_	IN	IN	_	12	NMOD	_	_
14	heparin	_	NN	NN	_	13	PMOD	_	_
15	was	_	VBD	VBD	_	10	AMOD	_	_
16	responsible	_	JJ	JJ	_	15	PRD	_	_
17	for	_	IN	IN	_	16	AMOD	_	_
18	the	_	DT	DT	_	20	NMOD	_	_
19	bad	_	JJ	JJ	_	20	NMOD	_	_
20	reactions	_	NNS	NNS	_	17	PMOD	_	_
21	,	_	,	,	_	4	P	_	_
22	according	_	VBG	VBG	_	4	VMOD	_	_
23	to	_	TO	TO	_	24	VMOD	_	_
24	@	_	VB	VB	_	22	VMOD	_	_
25	entity79	_	CD	CD	_	24	OBJ	_	_

1	they	_	PRP	PRP	_	2	SUB	_	_
2	said	_	VBD	VBD	_	0	ROOT	_	_
3	the	_	DT	DT	_	4	NMOD	_	_
4	contamination	_	NN	NN	_	5	SUB	_	_
5	might	_	MD	MD	_	2	VMOD	_	_
6	have	_	VB	VB	_	5	VC	_	_
7	occurred	_	VBN	VBN	_	6	VC	_	_
8	in	_	IN	IN	_	7	VMOD	_	_
9	the	_	DT	DT	_	10	NMOD	_	_
10	@	_	NN	NN	_	8	PMOD	_	_
11	entity20	_	CD	CD	_	10	NMOD	_	_
12	during	_	IN	IN	_	7	VMOD	_	_
13	the	_	DT	DT	_	15	NMOD	_	_
14	manufacturing	_	NN	NN	_	15	NMOD	_	_
15	process	_	NN	NN	_	17	NMOD	_	_
16	or	_	CC	CC	_	17	NMOD	_	_
17	patients	_	NNS	NNS	_	18	SUB	_	_
18	may	_	MD	MD	_	12	SBAR	_	_
19	have	_	VB	VB	_	18	VC	_	_
20	had	_	VBD	VBD	_	19	VC	_	_
21	conditions	_	NNS	NNS	_	20	OBJ	_	_
22	that	_	WDT	WDT	_	21	NMOD	_	_
23	caused	_	VBD	VBD	_	22	SBAR	_	_
24	the	_	DT	DT	_	25	NMOD	_	_
25	symptoms	_	NNS	NNS	_	23	OBJ	_	_

1	watch	_	NN	NN	_	2	NMOD	_	_
2	dr	_	NN	NN	_	0	ROOT	_	_

1	@	_	NNP	NNP	_	3	SUB	_	_
2	entity85	_	CD	CD	_	1	NMOD	_	_
3	explain	_	VBP	VBP	_	31	VMOD	_	_
4	the	_	DT	DT	_	5	NMOD	_	_
5	controversy	_	NN	NN	_	3	OBJ	_	_
6	over	_	IN	IN	_	5	NMOD	_	_
7	heparin	_	JJ	JJ	_	8	NMOD	_	_
8	Â»	_	NN	NN	_	6	PMOD	_	_
9	``	_	``	``	_	8	P	_	_
10	we	_	PRP	PRP	_	11	SUB	_	_
11	are	_	VBP	VBP	_	8	NMOD	_	_
12	aware	_	JJ	JJ	_	11	PRD	_	_
13	that	_	IN	IN	_	12	AMOD	_	_
14	our	_	PRP$	PRP$	_	17	NMOD	_	_
15	@	_	NN	NN	_	17	NMOD	_	_
16	entity9	_	CD	CD	_	17	NMOD	_	_
17	colleagues	_	NNS	NNS	_	18	SUB	_	_
18	are	_	VBP	VBP	_	13	SBAR	_	_
19	skeptical	_	JJ	JJ	_	18	PRD	_	_
20	that	_	IN	IN	_	19	AMOD	_	_
21	such	_	PDT	PDT	_	23	NMOD	_	_
22	a	_	DT	DT	_	23	NMOD	_	_
23	link	_	NN	NN	_	24	SUB	_	_
24	has	_	VBZ	VBZ	_	20	SBAR	_	_
25	been	_	VBN	VBN	_	24	VC	_	_
26	established	_	VBN	VBN	_	25	VC	_	_
27	,	_	,	,	_	31	P	_	_
28	``	_	``	``	_	31	P	_	_
29	@	_	NN	NN	_	30	NMOD	_	_
30	entity11	_	NN	NN	_	31	SUB	_	_
31	said	_	VBD	VBD	_	0	ROOT	_	_

1	``	_	``	``	_	3	P	_	_
2	we	_	PRP	PRP	_	3	SUB	_	_
3	are	_	VBP	VBP	_	0	ROOT	_	_
4	hoping	_	VBG	VBG	_	3	VC	_	_
5	for	_	IN	IN	_	4	VMOD	_	_
6	further	_	RBR	RBR	_	8	NMOD	_	_
7	scientific	_	JJ	JJ	_	8	NMOD	_	_
8	dialogue	_	NN	NN	_	17	SUB	_	_
9	with	_	IN	IN	_	8	NMOD	_	_
10	them	_	PRP	PRP	_	9	PMOD	_	_
11	in	_	IN	IN	_	8	NMOD	_	_
12	the	_	DT	DT	_	15	NMOD	_	_
13	next	_	JJ	JJ	_	15	NMOD	_	_
14	few	_	JJ	JJ	_	15	NMOD	_	_
15	weeks	_	NNS	NNS	_	11	PMOD	_	_
16	to	_	TO	TO	_	17	VMOD	_	_
17	present	_	VB	VB	_	5	SBAR	_	_
18	the	_	DT	DT	_	19	NMOD	_	_
19	data	_	NNS	NNS	_	17	OBJ	_	_

1	``	_	``	``	_	30	P	_	_
2	the	_	DT	DT	_	4	NMOD	_	_
3	raw	_	JJ	JJ	_	4	NMOD	_	_
4	ingredient	_	NN	NN	_	14	SUB	_	_
5	for	_	IN	IN	_	4	NMOD	_	_
6	heparin	_	NN	NN	_	5	PMOD	_	_
7	sold	_	VBN	VBN	_	4	NMOD	_	_
8	by	_	IN	IN	_	7	VMOD	_	_
9	@	_	VBG	VBG	_	8	PMOD	_	_
10	entity96	_	CD	CD	_	9	OBJ	_	_
11	and	_	CC	CC	_	7	VMOD	_	_
12	ordered	_	VBD	VBD	_	7	VMOD	_	_
13	recalled	_	VBN	VBN	_	12	VC	_	_
14	came	_	VBD	VBD	_	30	VMOD	_	_
15	from	_	IN	IN	_	14	VMOD	_	_
16	@	_	NN	NN	_	15	PMOD	_	_
17	entity97	_	CD	CD	_	16	NMOD	_	_
18	,	_	,	,	_	30	P	_	_
19	a	_	DT	DT	_	22	NMOD	_	_
20	@	_	JJ	JJ	_	22	NMOD	_	_
21	entity98	_	CD	CD	_	22	NMOD	_	_
22	company	_	NN	NN	_	30	SUB	_	_
23	that	_	WDT	WDT	_	22	NMOD	_	_
24	owns	_	VBZ	VBZ	_	23	SBAR	_	_
25	@	_	CD	CD	_	26	AMOD	_	_
26	entity99	_	CD	CD	_	28	NMOD	_	_
27	the	_	DT	DT	_	28	NMOD	_	_
28	@	_	NN	NN	_	24	OBJ	_	_
29	entity2	_	CD	CD	_	28	NMOD	_	_
30	posted	_	VBD	VBD	_	0	ROOT	_	_
31	on	_	IN	IN	_	30	VMOD	_	_
32	its	_	PRP$	PRP$	_	34	NMOD	_	_
33	web	_	JJ	JJ	_	34	NMOD	_	_
34	site	_	NN	NN	_	31	PMOD	_	_
35	a	_	DT	DT	_	37	NMOD	_	_
36	warning	_	VBG	VBG	_	37	NMOD	_	_
37	letter	_	NN	NN	_	34	OBJ	_	_
38	to	_	TO	TO	_	39	VMOD	_	_
39	@	_	VB	VB	_	37	NMOD	_	_
40	entity99	_	CD	CD	_	39	OBJ	_	_

1	the	_	DT	DT	_	2	NMOD	_	_
2	letter	_	NN	NN	_	3	SUB	_	_
3	said	_	VBD	VBD	_	0	ROOT	_	_
4	the	_	DT	DT	_	5	NMOD	_	_
5	company	_	NN	NN	_	6	SUB	_	_
6	has	_	VBZ	VBZ	_	3	VMOD	_	_
7	not	_	RB	RB	_	6	VMOD	_	_
8	instituted	_	VBN	VBN	_	6	VC	_	_
9	proper	_	JJ	JJ	_	10	NMOD	_	_
10	safeguards	_	NNS	NNS	_	8	OBJ	_	_
11	to	_	TO	TO	_	12	VMOD	_	_
12	ensure	_	VB	VB	_	8	VMOD	_	_
13	the	_	DT	DT	_	15	NMOD	_	_
14	raw	_	JJ	JJ	_	15	NMOD	_	_
15	materials	_	NNS	NNS	_	16	SUB	_	_
16	are	_	VBP	VBP	_	12	VMOD	_	_
17	free	_	JJ	JJ	_	16	PRD	_	_
18	of	_	IN	IN	_	17	AMOD	_	_
19	impurities	_	NNS	NNS	_	18	PMOD	_	_

1	``	_	``	``	_	35	P	_	_
2	you	_	PRP	PRP	_	3	SUB	_	_
3	fail	_	VBP	VBP	_	35	VMOD	_	_
4	to	_	TO	TO	_	5	VMOD	_	_
5	have	_	VB	VB	_	3	VMOD	_	_
6	adequate	_	JJ	JJ	_	7	NMOD	_	_
7	systems	_	NNS	NNS	_	5	OBJ	_	_
8	for	_	IN	IN	_	7	NMOD	_	_
9	evaluating	_	VBG	VBG	_	8	PMOD	_	_
10	the	_	DT	DT	_	11	NMOD	_	_
11	suppliers	_	NNS	NNS	_	9	OBJ	_	_
12	of	_	IN	IN	_	11	NMOD	_	_
13	heparin	_	JJ	JJ	_	15	NMOD	_	_
14	crude	_	JJ	JJ	_	15	NMOD	_	_
15	materials	_	NNS	NNS	_	20	NMOD	_	_
16	,	_	,	,	_	20	P	_	_
17	and	_	CC	CC	_	20	NMOD	_	_
18	the	_	DT	DT	_	20	NMOD	_	_
19	crude	_	JJ	JJ	_	20	NMOD	_	_
20	materials	_	NNS	NNS	_	12	PMOD	_	_
21	themselves	_	PRP	PRP	_	23	SUB	_	_
22	to	_	TO	TO	_	23	VMOD	_	_
23	ensure	_	VB	VB	_	20	NMOD	_	_
24	that	_	IN	IN	_	23	VMOD	_	_
25	these	_	DT	DT	_	26	NMOD	_	_
26	materials	_	NNS	NNS	_	27	SUB	_	_
27	are	_	VBP	VBP	_	24	SBAR	_	_
28	acceptable	_	JJ	JJ	_	27	PRD	_	_
29	for	_	IN	IN	_	28	AMOD	_	_
30	use	_	NN	NN	_	29	PMOD	_	_
31	,	_	,	,	_	35	P	_	_
32	``	_	``	``	_	35	P	_	_
33	the	_	DT	DT	_	34	NMOD	_	_
34	letter	_	NN	NN	_	35	SUB	_	_
35	said	_	VBD	VBD	_	0	ROOT	_	_

1	it	_	PRP	PRP	_	3	SUB	_	_
2	also	_	RB	RB	_	3	VMOD	_	_
3	cited	_	VBD	VBD	_	0	ROOT	_	_
4	equipment	_	NN	NN	_	3	OBJ	_	_
5	used	_	VBN	VBN	_	4	NMOD	_	_
6	in	_	IN	IN	_	5	VMOD	_	_
7	the	_	DT	DT	_	8	NMOD	_	_
8	manufacture	_	NN	NN	_	6	PMOD	_	_
9	of	_	IN	IN	_	8	NMOD	_	_
10	heparin	_	NN	NN	_	9	PMOD	_	_
11	as	_	IN	IN	_	5	VMOD	_	_
12	``	_	``	``	_	11	P	_	_
13	unsuitable	_	JJ	JJ	_	11	PMOD	_	_
14	for	_	IN	IN	_	13	AMOD	_	_
15	intended	_	JJ	JJ	_	16	NMOD	_	_
16	use	_	NN	NN	_	14	PMOD	_	_

1	``	_	``	``	_	24	P	_	_
2	for	_	IN	IN	_	24	VMOD	_	_
3	example	_	NN	NN	_	2	PMOD	_	_
4	,	_	,	,	_	6	P	_	_
5	it	_	PRP	PRP	_	6	SUB	_	_
6	said	_	VBD	VBD	_	24	VMOD	_	_
7	,	_	,	,	_	6	P	_	_
8	tanks	_	NNS	NNS	_	9	SUB	_	_
9	used	_	VBD	VBD	_	24	VMOD	_	_
10	to	_	TO	TO	_	11	VMOD	_	_
11	make	_	VB	VB	_	9	VMOD	_	_
12	heparin	_	JJ	JJ	_	11	VMOD	_	_
13	``	_	``	``	_	24	P	_	_
14	were	_	VBD	VBD	_	24	VMOD	_	_
15	identified	_	VBN	VBN	_	14	VC	_	_
16	as	_	IN	IN	_	15	VMOD	_	_
17	clean	_	JJ	JJ	_	16	PMOD	_	_
18	,	_	,	,	_	24	P	_	_
19	``	_	``	``	_	24	P	_	_
20	but	_	CC	CC	_	24	VMOD	_	_
21	``	_	``	``	_	24	P	_	_
22	unidentified	_	JJ	JJ	_	23	NMOD	_	_
23	material	_	NN	NN	_	24	SUB	_	_
24	was	_	VBD	VBD	_	0	ROOT	_	_
25	observed	_	VBN	VBN	_	24	VC	_	_
26	adhering	_	VBG	VBG	_	25	VMOD	_	_
27	to	_	TO	TO	_	26	VMOD	_	_
28	the	_	DT	DT	_	30	NMOD	_	_
29	inside	_	JJ	JJ	_	30	NMOD	_	_
30	surfaces	_	NNS	NNS	_	27	PMOD	_	_

1	``	_	``	``	_	28	P	_	_
2	shipments	_	NNS	NNS	_	12	SUB	_	_
3	of	_	IN	IN	_	2	NMOD	_	_
4	the	_	DT	DT	_	6	NMOD	_	_
5	company	_	NN	NN	_	6	NMOD	_	_
6	's	_	POS	POS	_	7	NMOD	_	_
7	materials	_	NNS	NNS	_	3	PMOD	_	_
8	made	_	VBD	VBD	_	7	NMOD	_	_
9	at	_	IN	IN	_	8	VMOD	_	_
10	the	_	DT	DT	_	11	NMOD	_	_
11	plant	_	NN	NN	_	9	PMOD	_	_
12	will	_	MD	MD	_	28	VMOD	_	_
13	be	_	VB	VB	_	12	VC	_	_
14	refused	_	VBN	VBN	_	13	VC	_	_
15	admission	_	NN	NN	_	14	OBJ	_	_
16	into	_	IN	IN	_	14	VMOD	_	_
17	the	_	DT	DT	_	18	NMOD	_	_
18	@	_	NN	NN	_	16	PMOD	_	_
19	entity20	_	CD	CD	_	18	NMOD	_	_
20	until	_	IN	IN	_	14	VMOD	_	_
21	the	_	DT	DT	_	22	NMOD	_	_
22	matter	_	NN	NN	_	23	SUB	_	_
23	is	_	VBZ	VBZ	_	20	SBAR	_	_
24	corrected	_	VBN	VBN	_	23	VC	_	_
25	,	_	,	,	_	28	P	_	_
26	the	_	DT	DT	_	27	NMOD	_	_
27	letter	_	NN	NN	_	28	SUB	_	_
28	said	_	VBD	VBD	_	0	ROOT	_	_

1	``	_	``	``	_	43	P	_	_
2	we	_	PRP	PRP	_	3	SUB	_	_
3	regret	_	VBP	VBP	_	19	VMOD	_	_
4	@	_	VBG	VBG	_	3	VC	_	_
5	entity2	_	CD	CD	_	6	NMOD	_	_
6	's	_	POS	POS	_	7	NMOD	_	_
7	decision	_	NN	NN	_	4	OBJ	_	_
8	to	_	TO	TO	_	9	VMOD	_	_
9	send	_	VB	VB	_	7	NMOD	_	_
10	a	_	DT	DT	_	12	NMOD	_	_
11	warning	_	VBG	VBG	_	12	NMOD	_	_
12	letter	_	NN	NN	_	9	OBJ	_	_
13	to	_	TO	TO	_	14	VMOD	_	_
14	@	_	VB	VB	_	12	NMOD	_	_
15	entity99	_	CD	CD	_	14	OBJ	_	_
16	,	_	,	,	_	19	P	_	_
17	and	_	CC	CC	_	19	VMOD	_	_
18	we	_	PRP	PRP	_	19	SUB	_	_
19	do	_	VBP	VBP	_	43	VMOD	_	_
20	not	_	RB	RB	_	19	VMOD	_	_
21	believe	_	VB	VB	_	19	VC	_	_
22	that	_	IN	IN	_	21	VMOD	_	_
23	the	_	DT	DT	_	25	NMOD	_	_
24	warning	_	VBG	VBG	_	25	NMOD	_	_
25	letter	_	NN	NN	_	26	SUB	_	_
26	reflects	_	VBZ	VBZ	_	22	SBAR	_	_
27	@	_	VBG	VBG	_	26	VMOD	_	_
28	entity99	_	CD	CD	_	29	NMOD	_	_
29	's	_	POS	POS	_	31	NMOD	_	_
30	actual	_	JJ	JJ	_	31	NMOD	_	_
31	state	_	NN	NN	_	27	OBJ	_	_
32	of	_	IN	IN	_	31	NMOD	_	_
33	compliance	_	NN	NN	_	32	PMOD	_	_
34	with	_	IN	IN	_	33	NMOD	_	_
35	current	_	JJ	JJ	_	38	NMOD	_	_
36	good	_	JJ	JJ	_	38	NMOD	_	_
37	manufacturing	_	NN	NN	_	38	NMOD	_	_
38	practices	_	NNS	NNS	_	34	PMOD	_	_
39	,	_	,	,	_	43	P	_	_
40	``	_	``	``	_	43	P	_	_
41	@	_	NN	NN	_	43	SUB	_	_
42	entity97	_	CD	CD	_	41	NMOD	_	_
43	said	_	VBD	VBD	_	0	ROOT	_	_
44	in	_	IN	IN	_	43	VMOD	_	_
45	a	_	DT	DT	_	47	NMOD	_	_
46	written	_	VBN	VBN	_	47	NMOD	_	_
47	statement	_	NN	NN	_	44	PMOD	_	_

1	it	_	PRP	PRP	_	2	SUB	_	_
2	added	_	VBD	VBD	_	0	ROOT	_	_
3	that	_	IN	IN	_	2	VMOD	_	_
4	it	_	PRP	PRP	_	5	SUB	_	_
5	is	_	VBZ	VBZ	_	3	SBAR	_	_
6	``	_	``	``	_	5	P	_	_
7	committed	_	VBN	VBN	_	5	VC	_	_
8	to	_	TO	TO	_	7	VMOD	_	_
9	cooperating	_	VBG	VBG	_	8	PMOD	_	_
10	with	_	IN	IN	_	9	VMOD	_	_
11	@	_	NN	NN	_	10	PMOD	_	_
12	entity2	_	CD	CD	_	11	NMOD	_	_
13	and	_	CC	CC	_	5	VMOD	_	_
14	will	_	MD	MD	_	5	VMOD	_	_
15	promptly	_	RB	RB	_	14	VMOD	_	_
16	provide	_	VB	VB	_	14	VC	_	_
17	a	_	DT	DT	_	19	NMOD	_	_
18	detailed	_	JJ	JJ	_	19	NMOD	_	_
19	response	_	NN	NN	_	16	OBJ	_	_

1	``	_	``	``	_	26	P	_	_
2	in	_	IN	IN	_	26	VMOD	_	_
3	a	_	DT	DT	_	5	NMOD	_	_
4	written	_	VBN	VBN	_	5	NMOD	_	_
5	statement	_	NN	NN	_	2	PMOD	_	_
6	,	_	,	,	_	26	P	_	_
7	@	_	VBD	VBD	_	26	VMOD	_	_
8	entity96	_	CD	CD	_	7	VMOD	_	_
9	said	_	VBD	VBD	_	26	VMOD	_	_
10	its	_	PRP$	PRP$	_	11	NMOD	_	_
11	tests	_	NNS	NNS	_	12	SUB	_	_
12	confirmed	_	VBD	VBD	_	9	VMOD	_	_
13	that	_	IN	IN	_	12	VMOD	_	_
14	the	_	DT	DT	_	15	NMOD	_	_
15	contaminant	_	NN	NN	_	16	SUB	_	_
16	can	_	MD	MD	_	13	SBAR	_	_
17	cause	_	VB	VB	_	16	VC	_	_
18	drops	_	NNS	NNS	_	17	OBJ	_	_
19	in	_	IN	IN	_	18	NMOD	_	_
20	blood	_	NN	NN	_	21	NMOD	_	_
21	pressure	_	NN	NN	_	19	PMOD	_	_
22	,	_	,	,	_	26	P	_	_
23	the	_	DT	DT	_	25	NMOD	_	_
24	most	_	RBS	RBS	_	25	AMOD	_	_
25	commonly	_	RB	RB	_	26	VMOD	_	_
26	reported	_	VBN	VBN	_	0	ROOT	_	_
27	adverse	_	JJ	JJ	_	28	NMOD	_	_
28	event	_	NN	NN	_	26	OBJ	_	_

1	``	_	``	``	_	51	P	_	_
2	that	_	DT	DT	_	3	SUB	_	_
3	means	_	VBZ	VBZ	_	51	VMOD	_	_
4	that	_	IN	IN	_	3	VMOD	_	_
5	the	_	DT	DT	_	6	NMOD	_	_
6	contaminant	_	NN	NN	_	37	SUB	_	_
7	,	_	,	,	_	6	P	_	_
8	which	_	WDT	WDT	_	6	NMOD	_	_
9	was	_	VBD	VBD	_	8	SBAR	_	_
10	introduced	_	VBN	VBN	_	9	VC	_	_
11	at	_	IN	IN	_	10	VMOD	_	_
12	the	_	DT	DT	_	13	NMOD	_	_
13	workshop	_	NN	NN	_	11	PMOD	_	_
14	of	_	IN	IN	_	13	NMOD	_	_
15	consolidator	_	NN	NN	_	16	NMOD	_	_
16	level	_	NN	NN	_	14	PMOD	_	_
17	,	_	,	,	_	10	P	_	_
18	before	_	IN	IN	_	10	VMOD	_	_
19	it	_	PRP	PRP	_	20	SUB	_	_
20	reached	_	VBD	VBD	_	18	SBAR	_	_
21	our	_	PRP$	PRP$	_	22	NMOD	_	_
22	@	_	NN	NN	_	29	NMOD	_	_
23	entity153	_	CD	CD	_	29	NMOD	_	_
24	[	_	NN	NN	_	29	NMOD	_	_
25	active	_	JJ	JJ	_	29	NMOD	_	_
26	pharmaceutical	_	JJ	JJ	_	29	NMOD	_	_
27	ingredient	_	NN	NN	_	29	NMOD	_	_
28	]	_	NN	NN	_	29	NMOD	_	_
29	supplier	_	NN	NN	_	20	OBJ	_	_
30	and	_	CC	CC	_	20	VMOD	_	_
31	before	_	IN	IN	_	20	VMOD	_	_
32	it	_	PRP	PRP	_	33	SUB	_	_
33	reached	_	VBD	VBD	_	31	SBAR	_	_
34	@	_	VBG	VBG	_	33	VMOD	_	_
35	entity96	_	CD	CD	_	34	OBJ	_	_
36	,	_	,	,	_	6	P	_	_
37	is	_	VBZ	VBZ	_	4	SBAR	_	_
38	likely	_	JJ	JJ	_	37	PRD	_	_
39	the	_	DT	DT	_	40	NMOD	_	_
40	cause	_	NN	NN	_	38	OBJ	_	_
41	of	_	IN	IN	_	40	NMOD	_	_
42	the	_	DT	DT	_	45	NMOD	_	_
43	increased	_	JJ	JJ	_	45	NMOD	_	_
44	adverse	_	JJ	JJ	_	45	NMOD	_	_
45	reactions	_	NNS	NNS	_	41	PMOD	_	_
46	to	_	TO	TO	_	45	NMOD	_	_
47	the	_	DT	DT	_	48	NMOD	_	_
48	heparin	_	NN	NN	_	46	PMOD	_	_
49	,	_	,	,	_	51	P	_	_
50	``	_	``	``	_	51	P	_	_
51	said	_	VBD	VBD	_	0	ROOT	_	_
52	@	_	JJ	JJ	_	53	NMOD	_	_
53	entity147	_	CD	CD	_	60	NMOD	_	_
54	,	_	,	,	_	60	P	_	_
55	the	_	DT	DT	_	57	NMOD	_	_
56	company	_	NN	NN	_	57	NMOD	_	_
57	's	_	POS	POS	_	60	NMOD	_	_
58	chief	_	JJ	JJ	_	60	NMOD	_	_
59	scientific	_	JJ	JJ	_	60	NMOD	_	_
60	officer	_	NN	NN	_	51	SUB	_	_

1	because	_	IN	IN	_	16	VMOD	_	_
2	no	_	DT	DT	_	3	NMOD	_	_
3	method	_	NN	NN	_	4	SUB	_	_
4	existed	_	VBD	VBD	_	1	SBAR	_	_
5	to	_	TO	TO	_	6	VMOD	_	_
6	test	_	VB	VB	_	4	VMOD	_	_
7	for	_	IN	IN	_	6	VMOD	_	_
8	the	_	DT	DT	_	9	NMOD	_	_
9	contaminant	_	NN	NN	_	7	PMOD	_	_
10	,	_	,	,	_	16	P	_	_
11	the	_	DT	DT	_	15	NMOD	_	_
12	@	_	NN	NN	_	15	NMOD	_	_
13	entity2	_	CD	CD	_	15	NMOD	_	_
14	last	_	JJ	JJ	_	15	NMOD	_	_
15	month	_	NN	NN	_	16	VMOD	_	_
16	developed	_	VBD	VBD	_	21	VMOD	_	_
17	one	_	CD	CD	_	16	OBJ	_	_
18	,	_	,	,	_	21	P	_	_
19	and	_	CC	CC	_	21	VMOD	_	_
20	regulators	_	NNS	NNS	_	21	SUB	_	_
21	are	_	VBP	VBP	_	36	VMOD	_	_
22	now	_	RB	RB	_	21	VMOD	_	_
23	confident	_	JJ	JJ	_	25	NMOD	_	_
24	current	_	JJ	JJ	_	25	NMOD	_	_
25	@	_	NN	NN	_	21	PRD	_	_
26	entity20	_	CD	CD	_	27	NMOD	_	_
27	supplies	_	NNS	NNS	_	31	SUB	_	_
28	of	_	IN	IN	_	27	NMOD	_	_
29	the	_	DT	DT	_	30	NMOD	_	_
30	drug	_	NN	NN	_	28	PMOD	_	_
31	are	_	VBP	VBP	_	21	VMOD	_	_
32	safe	_	JJ	JJ	_	31	PRD	_	_
33	,	_	,	,	_	36	P	_	_
34	@	_	JJ	JJ	_	36	SUB	_	_
35	entity11	_	CD	CD	_	34	AMOD	_	_
36	said	_	VBD	VBD	_	0	ROOT	_	_

1	it	_	PRP	PRP	_	2	SUB	_	_
2	remains	_	VBZ	VBZ	_	17	VMOD	_	_
3	unclear	_	JJ	JJ	_	2	PRD	_	_
4	where	_	WRB	WRB	_	2	VMOD	_	_
5	the	_	DT	DT	_	6	NMOD	_	_
6	contamination	_	NN	NN	_	7	SUB	_	_
7	occurred	_	VBD	VBD	_	4	SBAR	_	_
8	,	_	,	,	_	17	P	_	_
9	but	_	CC	CC	_	17	VMOD	_	_
10	the	_	DT	DT	_	13	NMOD	_	_
11	contaminated	_	VBN	VBN	_	13	NMOD	_	_
12	products	_	NNS	NNS	_	13	NMOD	_	_
13	'	_	POS	POS	_	16	NMOD	_	_
14	active	_	JJ	JJ	_	16	NMOD	_	_
15	pharmaceutical	_	JJ	JJ	_	16	NMOD	_	_
16	ingredient	_	NN	NN	_	17	SUB	_	_
17	came	_	VBD	VBD	_	37	VMOD	_	_
18	from	_	IN	IN	_	17	VMOD	_	_
19	12	_	CD	CD	_	20	NMOD	_	_
20	@	_	NN	NN	_	22	NMOD	_	_
21	entity9	_	CD	CD	_	22	NMOD	_	_
22	makers	_	NNS	NNS	_	18	PMOD	_	_
23	of	_	IN	IN	_	22	NMOD	_	_
24	crude	_	JJ	JJ	_	25	NMOD	_	_
25	heparin	_	NN	NN	_	23	PMOD	_	_
26	``	_	``	``	_	17	P	_	_
27	across	_	IN	IN	_	17	VMOD	_	_
28	a	_	DT	DT	_	30	NMOD	_	_
29	broad	_	JJ	JJ	_	30	NMOD	_	_
30	area	_	NN	NN	_	27	PMOD	_	_
31	of	_	IN	IN	_	30	NMOD	_	_
32	@	_	NN	NN	_	31	PMOD	_	_
33	entity9	_	CD	CD	_	32	NMOD	_	_
34	,	_	,	,	_	37	P	_	_
35	``	_	``	``	_	37	P	_	_
36	she	_	PRP	PRP	_	37	SUB	_	_
37	said	_	VBD	VBD	_	0	ROOT	_	_

1	the	_	DT	DT	_	4	NMOD	_	_
2	most	_	RBS	RBS	_	3	AMOD	_	_
3	persuasive	_	JJ	JJ	_	4	NMOD	_	_
4	evidence	_	NN	NN	_	14	SUB	_	_
5	implicating	_	VBG	VBG	_	4	NMOD	_	_
6	the	_	DT	DT	_	9	NMOD	_	_
7	@	_	NN	NN	_	9	NMOD	_	_
8	entity9	_	CD	CD	_	9	NMOD	_	_
9	product	_	NN	NN	_	5	OBJ	_	_
10	,	_	,	,	_	12	P	_	_
11	she	_	PRP	PRP	_	12	SUB	_	_
12	said	_	VBD	VBD	_	14	VMOD	_	_
13	,	_	,	,	_	12	P	_	_
14	is	_	VBZ	VBZ	_	0	ROOT	_	_
15	the	_	DT	DT	_	16	NMOD	_	_
16	fact	_	NN	NN	_	14	PRD	_	_
17	that	_	IN	IN	_	16	NMOD	_	_
18	the	_	DT	DT	_	20	NMOD	_	_
19	increased	_	JJ	JJ	_	20	NMOD	_	_
20	number	_	NN	NN	_	27	SUB	_	_
21	of	_	IN	IN	_	20	NMOD	_	_
22	deaths	_	NNS	NNS	_	21	PMOD	_	_
23	reported	_	VBN	VBN	_	22	NMOD	_	_
24	after	_	IN	IN	_	23	VMOD	_	_
25	heparin	_	JJ	JJ	_	26	NMOD	_	_
26	administration	_	NN	NN	_	24	PMOD	_	_
27	returned	_	VBD	VBD	_	17	SBAR	_	_
28	to	_	TO	TO	_	27	VMOD	_	_
29	baseline	_	NN	NN	_	28	PMOD	_	_
30	in	_	IN	IN	_	27	VMOD	_	_
31	march	_	NN	NN	_	30	PMOD	_	_
32	,	_	,	,	_	27	P	_	_
33	after	_	IN	IN	_	27	VMOD	_	_
34	the	_	DT	DT	_	37	NMOD	_	_
35	@	_	JJ	JJ	_	37	NMOD	_	_
36	entity2	_	CD	CD	_	37	NMOD	_	_
37	recall	_	NN	NN	_	33	PMOD	_	_

1	though	_	IN	IN	_	25	VMOD	_	_
2	@	_	JJ	JJ	_	4	NMOD	_	_
3	entity9	_	CD	CD	_	4	NMOD	_	_
4	officials	_	NNS	NNS	_	5	SUB	_	_
5	have	_	VBP	VBP	_	1	SBAR	_	_
6	raised	_	VBN	VBN	_	5	VC	_	_
7	the	_	DT	DT	_	8	NMOD	_	_
8	possibility	_	NN	NN	_	6	OBJ	_	_
9	that	_	IN	IN	_	8	NMOD	_	_
10	clean	_	JJ	JJ	_	12	AMOD	_	_
11	and	_	CC	CC	_	12	AMOD	_	_
12	safe	_	JJ	JJ	_	13	NMOD	_	_
13	heparin	_	NN	NN	_	14	SUB	_	_
14	may	_	MD	MD	_	9	SBAR	_	_
15	have	_	VB	VB	_	14	VC	_	_
16	also	_	RB	RB	_	15	VMOD	_	_
17	been	_	VBN	VBN	_	15	VC	_	_
18	linked	_	VBN	VBN	_	17	VC	_	_
19	to	_	TO	TO	_	18	VMOD	_	_
20	adverse	_	JJ	JJ	_	21	NMOD	_	_
21	events	_	NNS	NNS	_	19	PMOD	_	_
22	,	_	,	,	_	25	P	_	_
23	@	_	RB	RB	_	25	VMOD	_	_
24	entity11	_	CD	CD	_	23	AMOD	_	_
25	discounted	_	VBD	VBD	_	0	ROOT	_	_
26	that	_	IN	IN	_	25	VMOD	_	_

1	``	_	``	``	_	12	P	_	_
2	we	_	PRP	PRP	_	3	SUB	_	_
3	tested	_	VBD	VBD	_	12	VMOD	_	_
4	this	_	DT	DT	_	5	NMOD	_	_
5	lot	_	NN	NN	_	3	OBJ	_	_
6	and	_	CC	CC	_	3	VMOD	_	_
7	found	_	VBD	VBD	_	3	VMOD	_	_
8	contamination	_	NN	NN	_	7	OBJ	_	_
9	,	_	,	,	_	12	P	_	_
10	``	_	``	``	_	12	P	_	_
11	she	_	PRP	PRP	_	12	SUB	_	_
12	said	_	VBD	VBD	_	0	ROOT	_	_

1	``	_	``	``	_	14	P	_	_
2	in	_	IN	IN	_	7	VMOD	_	_
3	their	_	PRP$	PRP$	_	4	NMOD	_	_
4	testing	_	NN	NN	_	2	PMOD	_	_
5	,	_	,	,	_	7	P	_	_
6	they	_	PRP	PRP	_	7	SUB	_	_
7	did	_	VBD	VBD	_	14	VMOD	_	_
8	not	_	RB	RB	_	7	VMOD	_	_
9	find	_	VB	VB	_	7	VC	_	_
10	contamination	_	NN	NN	_	9	OBJ	_	_
11	,	_	,	,	_	14	P	_	_
12	but	_	CC	CC	_	14	VMOD	_	_
13	we	_	PRP	PRP	_	14	SUB	_	_
14	are	_	VBP	VBP	_	0	ROOT	_	_
15	fairly	_	RB	RB	_	16	AMOD	_	_
16	certain	_	JJ	JJ	_	14	PRD	_	_
17	because	_	IN	IN	_	14	VMOD	_	_
18	of	_	IN	IN	_	17	PMOD	_	_
19	multiple	_	JJ	JJ	_	20	NMOD	_	_
20	labs	_	NNS	NNS	_	17	PMOD	_	_
21	doing	_	VBG	VBG	_	20	NMOD	_	_
22	the	_	DT	DT	_	23	NMOD	_	_
23	testing	_	NN	NN	_	21	OBJ	_	_
24	that	_	IN	IN	_	23	NMOD	_	_
25	this	_	DT	DT	_	26	NMOD	_	_
26	lot	_	NN	NN	_	27	SUB	_	_
27	contains	_	VBZ	VBZ	_	24	SBAR	_	_
28	contaminants	_	NNS	NNS	_	27	OBJ	_	_

1	``	_	``	``	_	2	P	_	_
2	e-mail	_	NN	NN	_	0	ROOT	_	_
3	to	_	TO	TO	_	2	NMOD	_	_
4	a	_	DT	DT	_	5	NMOD	_	_
5	friend	_	NN	NN	_	3	PMOD	_	_

